(Washington, DC) — Legislation championed by the independent drugstore lobby that would restrict many proven pharmacy benefit management cost-saving tools would increase the federal deficit by $186.2 billion and also increase costs to private plans by $105.7 billion over the 2010-2019 period, according to a new budget analysis conducted by the Moran Company.

HR 4199, the “Patient Health and Real Medication Access Cost Savings Act of 2009,“would destroy proven cost-containment tools that unions, large employers, and Medicare rely upon and would drive health care premiums higher for working families, seniors, and the disabled, the Pharmaceutical Care Management Association (PCMA) said today.

In conjunction with the new analysis, PCMA also launched a new ad campaign — “The Independent Pharmacy Lobby wants more… and it will only cost $l86 billion” — that highlights the independent drugstore lobby’s special interest agenda.

“The last thing consumers and payers want are new fees on prescription drugs and less access to affordable home delivery,” said PCMA President and CEO Mark Merritt. “The bill would simply transfer money from those who pay for drugs to the drugstores that dispense them.”

The bill would result in:

  • Higher cost-sharing for consumers.
  • Higher payments to drugstores.
  • Higher generic drug costs.
  • Less access to affordable home delivery of medications.

Read the press release.